oxycodone controlled release / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 58 Diseases   27 Trials   27 Trials   1449 News 


«123456789101112»
  • ||||||||||  oxycodone controlled release / generics
    Journal:  The Opioid Crisis and the Orthopedic Surgeon. (Pubmed Central) -  Mar 30, 2019   
    ...Before the opioid misuse epidemic, orthopedic surgeons were frequently influenced to "treat pain with pain medications." Long-acting opioids, such as OxyContin were used commonly...Third, we will look at perioperative interventions that can reduce postoperative opioid consumption, including wound injections and peripheral nerve blocks, which have shown superb clinical results. Finally, we will recommend an evidence-based program that avoids parenteral narcotics and facilitates rapid discharge home without readmissions for pain-related complaints.
  • ||||||||||  oxycodone controlled release / generics
    Journal:  The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons. (Pubmed Central) -  Mar 27, 2019   
    This study replicates the trend towards substitution of OxyContin® with other opioids following the introduction of reformulated OxyContin® in Australia and extends initial findings by showing the rate of overdose per MSIC visit increased following reformulation. These unintended consequences need to be considered when evaluating the success or otherwise of these kinds of changes in product formulation.
  • ||||||||||  dextromethorphan / Generic mfg.
    Trial completion date, Trial primary completion date:  Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion (clinicaltrials.gov) -  Mar 15, 2019   
    P3,  N=156, Recruiting, 
    CYP3A4*1G SNP is unlikely to affect pain relief efficacy of oxycontin. Trial completion date: Oct 2019 --> Jun 2019 | Trial primary completion date: Apr 2019 --> Jun 2019
  • ||||||||||  Trial completion date, Trial primary completion date, Surgery:  Pain Management in Head and Neck Surgery Patients (clinicaltrials.gov) -  Feb 27, 2019   
    P4,  N=60, Recruiting, 
    Trial completion date: Oct 2019 --> Jun 2019 | Trial primary completion date: Apr 2019 --> Jun 2019 Trial completion date: Jul 2020 --> Nov 2020 | Trial primary completion date: Jun 2019 --> Nov 2019
  • ||||||||||  oxycodone controlled release / Generic mfg., ibuprofen / Generic mfg.
    Biomarker, Trial completion date, Trial primary completion date:  Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes (clinicaltrials.gov) -  Feb 16, 2019   
    P4,  N=238, Recruiting, 
    Trial completion date: Jul 2020 --> Nov 2020 | Trial primary completion date: Jun 2019 --> Nov 2019 Trial completion date: Nov 2019 --> Nov 2020 | Trial primary completion date: Nov 2018 --> Nov 2019
  • ||||||||||  risperidone / Generic mfg., oxycodone controlled release / Generic mfg., ziprasidone / Generic mfg.
    New P1 trial:  Reducing the Abuse of Opioids in Drug Users (clinicaltrials.gov) -  Feb 11, 2019   
    P1,  N=25, Not yet recruiting, 
  • ||||||||||  oxycodone controlled release / Generic mfg., paracetamol / Generic mfg.
    New P2 trial:  Multimodal Pain Therapy After Hernia Repair (clinicaltrials.gov) -  Jan 3, 2019   
    P2,  N=200, Recruiting, 
  • ||||||||||  Trial completion date, Trial primary completion date, Surgery:  Pain Management in Head and Neck Surgery Patients (clinicaltrials.gov) -  Sep 19, 2018   
    P4,  N=60, Recruiting, 
    Phase classification: P1 --> P=N/A Trial completion date: Dec 2019 --> Jul 2020 | Trial primary completion date: Dec 2018 --> Jun 2019
  • ||||||||||  oxycodone ER (PF614) / Ensysce Biosciences
    Trial completion:  Study of PF614 Compared to OxyContin (clinicaltrials.gov) -  Jul 26, 2018   
    P1,  N=64, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  oxycodone controlled release / Generic mfg.
    Trial completion, Phase classification:  Early Use of Opioid in Radiation Mucositis (clinicaltrials.gov) -  Jul 17, 2018   
    P2,  N=200, Completed, 
    Recruiting --> Completed Not yet recruiting --> Completed | Phase classification: PN/A --> P2
  • ||||||||||  OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
    New P3 trial:  Multimodal Analgesia in Shoulder Arthroplasty (clinicaltrials.gov) -  Jul 16, 2018   
    P3,  N=74, Recruiting, 
  • ||||||||||  Enrollment closed, Trial completion date, Trial primary completion date:  Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block (clinicaltrials.gov) -  Apr 6, 2018   
    P3,  N=53, Active, not recruiting, 
    Not yet recruiting --> Completed | Phase classification: PN/A --> P2 Not yet recruiting --> Active, not recruiting | Trial completion date: Jan 2020 --> Apr 2019 | Trial primary completion date: Jan 2019 --> Apr 2019
  • ||||||||||  oxycodone controlled release / Generic mfg.
    Trial completion:  OTR Tablet 40 mg Fasted-state Bioequivalence Study (clinicaltrials.gov) -  Apr 2, 2018   
    P1,  N=38, Completed, 
    Not yet recruiting --> Active, not recruiting | Trial completion date: Jan 2020 --> Apr 2019 | Trial primary completion date: Jan 2019 --> Apr 2019 Recruiting --> Completed
  • ||||||||||  Remoxy ER (extended-release oxycodone capsules CII) / Cassava
    New P1 trial:  Nasal Human Abuse Potential of PTI-821 (clinicaltrials.gov) -  Mar 22, 2018   
    P1,  N=38, Completed, 
  • ||||||||||  oxycodone controlled release / Generic mfg.
    New P1 trial:  OTR Tablet 40 mg Fasted-state Bioequivalence Study (clinicaltrials.gov) -  Jan 23, 2018   
    P1,  N=38, Recruiting, 
  • ||||||||||  oxycodone ER (PF614) / Ensysce Biosciences
    Enrollment open, Enrollment change, Trial primary completion date:  Study of PF614 Compared to OxyContin (clinicaltrials.gov) -  Dec 5, 2017   
    P1,  N=64, Recruiting, 
    Trial primary completion date: Nov 2017 --> Jun 2018 Completed --> Recruiting | N=48 --> 64 | Trial primary completion date: Apr 2017 --> Jan 2018
  • ||||||||||  Trial primary completion date, Surgery:  Pain Management in Head and Neck Surgery Patients (clinicaltrials.gov) -  Nov 22, 2017   
    P4,  N=60, Recruiting, 
    N=130 --> 70 | Trial primary completion date: May 2017 --> May 2018 Trial primary completion date: Aug 2018 --> Dec 2018
  • ||||||||||  oxycodone controlled release / Generic mfg., ibuprofen / Generic mfg.
    Biomarker, Enrollment open, Phase classification, Trial initiation date, Trial primary completion date:  Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes (clinicaltrials.gov) -  Oct 26, 2017   
    P4,  N=238, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Phase classification: PN/A --> P4 | Initiation date: Nov 2016 --> Jul 2017 | Trial primary completion date: Nov 2017 --> Nov 2018
  • ||||||||||  Enrollment open, Surgery:  Pain Management in Head and Neck Surgery Patients (clinicaltrials.gov) -  Sep 14, 2017   
    P4,  N=60, Recruiting, 
    Not yet recruiting --> Recruiting | Phase classification: PN/A --> P4 | Initiation date: Nov 2016 --> Jul 2017 | Trial primary completion date: Nov 2017 --> Nov 2018 Not yet recruiting --> Recruiting
  • ||||||||||  oxycodone ER (PF614) / Ensysce Biosciences
    Trial completion:  Study of PF614 Compared to OxyContin (clinicaltrials.gov) -  Jul 27, 2017   
    P1,  N=48, Completed, 
    Recruiting --> Active, not recruiting | N=200 --> 105 Recruiting --> Completed
  • ||||||||||  Trial initiation date, Trial primary completion date, Surgery:  Pain Management in Head and Neck Surgery Patients (clinicaltrials.gov) -  Jun 21, 2017   
    P4,  N=60, Not yet recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Jan 2016 --> Sep 2016 Initiation date: May 2017 --> Aug 2017 | Trial primary completion date: May 2018 --> Aug 2018